MedTrace Logo

Genetic Architecture of Acute Aortic Syndromes and Aortic Aneurysm.

NCT06353607 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 730

Last updated 2025-05-16

No results posted yet for this study

Summary

The aim of this study is to explore the genetic information associated with the development of TAA and aAD in individuals without history or syndromic features (Marfan syndrome, Ehlers-Danlos syndrome, Turner syndrome etc.) for aortic disease. For this purpose, whole genome sequencing will be performed in patients with documented aortic aneurysm or/and aortic dissection.

Conditions

  • Acute Aortic Dissection
  • Thoracic Aortic Aneurysm

Sponsors & Collaborators

  • University Hospital, Basel, Switzerland

    lead OTHER

Principal Investigators

  • Denis Berdajs, Prof. Dr. · University Hospital, Basel, Switzerland

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-04-08
Primary Completion
2028-12-31
Completion
2028-12-31

Countries

  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06353607 on ClinicalTrials.gov